Acute Myocardial Infarction in SCAI Stage E Shock Patients Treated with Impella and PCI: Insights from the RECOVER III-Discussion

Video Transcription

Video Summary

In this episode of "Conversations in Interventional Cardiology," Dr. Andrew Goldsweig introduces discussions about a recent J-SCI publication, analyzing the RECOVER3 study concerning the use of Impella and PCI in stage E cardiogenic shock patients. The study is significant for insights into clinical practices and patient prognostication with these treatments. Dr. Ivan Hansen presented findings illustrating that half of the patients improve their shock stage within 24 hours, doubling their survival rate. Key predictors include using Impella pre-PCI and the number of revascularized vessels. Experts Drs. Naidu, Basir, and O'Neill discuss implications for management of cardiogenic shock, supporting the increased use of mechanical support early during care and suggesting further revision of the Sky Shock Classification to improve prognostic accuracy and guide treatment. The panel underscores the importance of early revascularization, de-escalation of pressors, and intensive follow-up care to enhance long-term outcomes in shock patients.

Keywords

Interventional Cardiology

RECOVER3 study

Impella

cardiogenic shock

revascularization

Sky Shock Classification